Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$174.81 - $241.14 $874,050 - $1.21 Million
-5,000 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$166.16 - $213.96 $830,800 - $1.07 Million
5,000 New
5,000 $897,000
Q4 2021

Jan 18, 2022

SELL
$184.32 - $216.08 $1.16 Million - $1.36 Million
-6,300 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$179.86 - $214.88 $1.13 Million - $1.35 Million
6,300 New
6,300 $1.16 Million
Q1 2021

Apr 14, 2021

SELL
$153.94 - $174.85 $1.37 Million - $1.56 Million
-8,900 Closed
0 $0
Q4 2020

Jan 13, 2021

SELL
$101.87 - $151.79 $183,366 - $273,222
-1,800 Reduced 16.82%
8,900 $1.35 Million
Q3 2020

Oct 07, 2020

BUY
$99.9 - $121.13 $1.07 Million - $1.3 Million
10,700 New
10,700 $1.08 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.